Daiwa Securities Group’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,094
Closed -$32K 1369
2023
Q4
$32K Buy
1,094
+206
+23% +$4.1K ﹤0.01% 1100
2023
Q3
$14K Hold
888
﹤0.01% 1114
2023
Q2
$17K Hold
888
﹤0.01% 1110
2023
Q1
$3K Hold
888
﹤0.01% 1199
2022
Q4
$4K Buy
888
+195
+28% +$1.06K ﹤0.01% 1176
2022
Q3
$3K Hold
693
﹤0.01% 1211
2022
Q2
$3K Hold
693
﹤0.01% 1215
2022
Q1
$3K Hold
693
﹤0.01% 1233
2021
Q4
$5K Hold
693
﹤0.01% 1208
2021
Q3
$4K Buy
693
+309
+80% +$1.78K ﹤0.01% 1203
2021
Q2
$3K Hold
384
﹤0.01% 1125
2021
Q1
$3K Hold
384
﹤0.01% 1125
2020
Q4
$2K Sell
384
-612
-61% -$3.57K ﹤0.01% 1145
2020
Q3
$4K Buy
996
+151
+18% +$610 ﹤0.01% 1109
2020
Q2
$3K Hold
845
﹤0.01% 1149
2020
Q1
$3K Hold
845
﹤0.01% 1148
2019
Q4
$4K Sell
845
-110
-12% -$373 ﹤0.01% 1137
2019
Q3
$2K Buy
955
+224
+31% +$595 ﹤0.01% 1140
2019
Q2
$2K Hold
731
﹤0.01% 1159
2019
Q1
$2K Hold
731
﹤0.01% 1146
2018
Q4
$4K Hold
731
﹤0.01% 1078
2018
Q3
$7K Hold
731
﹤0.01% 1068
2018
Q2
$7K Hold
731
﹤0.01% 1078
2018
Q1
$8K Buy
+731
New +$7.22K ﹤0.01% 1050

Other funds holding IMGN

Daiwa Securities Group's IMGN Position: Q1 2024 in Review

Daiwa Securities Group sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,094 shares — an estimated $32K sold.

Daiwa Securities Group first reported a position in IMGN in Q1 2018 and held it in 24 quarters. The position peaked at $32K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Daiwa Securities Group reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Daiwa Securities Group sold 1,094 Immunogen Inc shares in Q1 2024, an estimated $32K.
  • Daiwa Securities Group first reported a position in Immunogen Inc in Q1 2018 and held it in 24 quarters.
  • Daiwa Securities Group's Immunogen Inc position peaked at $32K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Daiwa Securities Group's 13F filing for Q1 2024, filed 2 May 2024.